Key facts
- Dose Insight’s last known valuation is $3.5M (Jan 2025).
- It has raised $550K; the latest was Early Stage VC ($550K) in Jan 2025.
- Notable investors include 1540 Ventures, U.S. Food and Drug Administration.
- Dose Insight has filed 1 Form D with the SEC, most recently Jan 2025 ($103K sold to 3 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dose Insight
- ·The full record, as it builds
Funding rounds
No funding rounds for Dose Insight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dose Insight
Provider of virtual dose mapping service intended for radiation sterilization. The company helps to sterilize medical devices and compares multiple design choices, enabling medical device companies to help reduce cost and accelerate time to market.
- Sector
- Healthcare
- HQ
- Sacramento, CA, United States
- Founded
- 2022
- Website
- doseinsight.com/
- Ownership
- Privately Held (backing)
Dose Insight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dose Insight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dose Insight in its N-PORT filings yet. We sweep new filings monthly.